Hyperlipidaemia type 3 - Apolipoprotein E deficiency (Q102532): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Envolve níveis anormalmente elevados de qualquer ou todos os lipídios e/ou lipoproteínas séricas. Esta forma é devido a quilomícrons elevados e IDL (lipoproteína de densidade intermediária). Também conhecida como doença beta ampla ou disbetalipoproteinemia, a causa mais comum dessa forma é a presença do genótipo ApoE E2/E2. É devido ao colesterol rico em VLDL. Este diagnóstico é devido à deficiência de apolipoproteína E. | |||||||||||||||
| description / en | description / en | ||||||||||||||
This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. This diagnosis is with apolipoprotein E deficiency. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1210107763 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1210107763 | |||||||||||||||
| Property / CURIE: CID11:ID_1210107763 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1210107763 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1210107763 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 19:35, 16 August 2026
This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. This diagnosis is with apolipoprotein E deficiency.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1210107763 |
||
| English | Hyperlipidaemia type 3 - Apolipoprotein E deficiency |
This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. This diagnosis is with apolipoprotein E deficiency. |
Statements
CID11:ID_1210107763
0 references
dki-india-ID_1210107763
0 references
Concluído
0 references
15 August 2026
0 references
